< Go back

IceCure’s Global Expansion Accelerates; Tumor Freezing Product Now Approved for Market in India

April 28, 2020

New Indian regulatory approval received for its cryoablation technology to destroy tumors in extensive indications, including for breast, lung, bone and kidney cancer. Read more.

IceCure Medical HQ: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel

Branding by